Achaogen, Inc. (AKAO)

0.02
0.00 4.59
NASDAQ
Prev Close 0.02
Open 0.02
Day Low/High 0.02 / 0.02
52 Wk Low/High 0.01 / 12.80
Volume 401.10K
Exchange NASDAQ
Shares Outstanding 63.88B
Market Cap 8.76M
Div & Yield N.A. (N.A)

Latest News

My Special Approach to Special Situations

My Special Approach to Special Situations

Drops in Achaogen and Sophiris Bio offered the chance to use an options strategy known as buy-write.

Strategies for 3 Biotechs Before FDA Action

Strategies for 3 Biotechs Before FDA Action

Leading up to potential FDA approvals can be particularly 'dicey' times for biotech investors.

3 Favorite Biotech Stocks for the Second Quarter

3 Favorite Biotech Stocks for the Second Quarter

Your questions are answered in our latest addition of the biotech mailbag.

7 Well-Known Stocks That Are Set to Reverse Direction

7 Well-Known Stocks That Are Set to Reverse Direction

These equities are showing technical characteristics of bullish and bearish reversal patterns.

2 Small Biotechs That Continue to Look Good

2 Small Biotechs That Continue to Look Good

Several biotech names held up well or even had solid advances during last week's broad market selloff.

2 Small Biotechs That Look Good

2 Small Biotechs That Look Good

Achaogen and Omeros both rose as the Dow was losing 724 points.

Small-Cap Biotech and Tech Names Part of Our Latest 'Sweet 16' Stock Picks

Small-Cap Biotech and Tech Names Part of Our Latest 'Sweet 16' Stock Picks

Real Money stock picks from Tim Collins, Skip Raschke, Jim Collins and Bret Jensen.

Big Dips Means Adding to My Holdings

Big Dips Means Adding to My Holdings

Achaogen, Taylor Morrison and Synchrony Financial are a part of my current shopping list.

Reversal Offers Chance in 2 Small Biotechs

Reversal Offers Chance in 2 Small Biotechs

I've added to my positions in these names on yesterday's intraday silliness.

Celgene Falls After Updates to 2017 Guidance, 2020 Targets -- Biotech Movers

Celgene Falls After Updates to 2017 Guidance, 2020 Targets -- Biotech Movers

The Summit, N.J.-based firm on Oct. 26 unveiled third-quarter results and updated its 2017 outlook and financial targets for 2020.

Trading Action Has Improved, Here's What I Am Playing

Trading Action Has Improved, Here's What I Am Playing

Market players are sorting out the winners and losers, and that produces good opportunities if we keep on digging.

Surge From Bank Earnings Doesn't Last

Surge From Bank Earnings Doesn't Last

Earnings and inauguration may be catalysts for the market.

Rev's Forum: The Fed Isn't Convinced the Trump Rally Is Justified

Rev's Forum: The Fed Isn't Convinced the Trump Rally Is Justified

Its members are skeptical about the market celebration and are not going to commit to a course of rate hikes until they have more data.

Trying to Knock Out Some Individual Trades, but it Is not Easy

Trying to Knock Out Some Individual Trades, but it Is not Easy

If the indices take out yesterday's lows I'll be very bearish very quickly.

Markets Are Rising But Feel Confused

Markets Are Rising But Feel Confused

Sometimes you just have to be patient and let the market come to you rather than force questionable entries.

Machines Are Pumping Up the Volume

Machines Are Pumping Up the Volume

There is no fundamental reason for DJIA volume to suddenly double and continue at that level.